Skip to main content
. 2016 Sep 17;7(47):76565–76576. doi: 10.18632/oncotarget.12088

Figure 7. Characterization of the immune infiltrate of pituitary tumors in tissue specimens.

Figure 7

A. Pan-lymphocyte marker CD45 expression in pituitary tumors classified according to tumor function, recurrence status, aggressiveness level, or proliferation status. B. CD3+ T lymphocyte, C. CD4+ T lymphocyte, D. CD8+ T lymphocyte and E. PD-1 expression in pituitary tumors. *p < 0.05.